Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Sertraline treatment of major depression in patients with acute MI or unstable angina.

Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, Mclvor M; Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group.

JAMA. 2002 Aug 14;288(6):701-9. Erratum in: JAMA 2002 Oct 9;288(14):1720.

PMID:
12169073
2.

Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.

Reddy S, Kane C, Pitrosky B, Musgnung J, Ninan PT, Guico-Pabia CJ.

Curr Med Res Opin. 2010 Jan;26(1):139-50. doi: 10.1185/03007990903408678. Review.

PMID:
19919295
3.

Sertraline: a review of its use in the management of major depressive disorder in elderly patients.

Muijsers RB, Plosker GL, Noble S.

Drugs Aging. 2002;19(5):377-92. Review.

PMID:
12093324
4.

Venlafaxine extended-release: a review of its use in the management of major depression.

Wellington K, Perry CM.

CNS Drugs. 2001;15(8):643-69. Review.

PMID:
11524036
5.

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.

Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.

Lancet. 2011 Jul 30;378(9789):403-11. doi: 10.1016/S0140-6736(11)60830-1. Epub 2011 Jul 19. Review.

PMID:
21764118
6.

Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials.

Gibiino S, Marsano A, Serretti A.

Int J Neuropsychopharmacol. 2014 Jan;17(1):1-8. doi: 10.1017/S1461145713000746. Epub 2013 Aug 19. Review.

PMID:
23953038
7.

Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents.

March JS, Klee BJ, Kremer CM.

J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):91-102. Review.

PMID:
16553531
8.

Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.

Trivedi MH, McGrath PJ, Fava M, Parsey RV, Kurian BT, Phillips ML, Oquendo MA, Bruder G, Pizzagalli D, Toups M, Cooper C, Adams P, Weyandt S, Morris DW, Grannemann BD, Ogden RT, Buckner R, McInnis M, Kraemer HC, Petkova E, Carmody TJ, Weissman MM.

J Psychiatr Res. 2016 Jul;78:11-23. doi: 10.1016/j.jpsychires.2016.03.001. Epub 2016 Mar 15. Review.

PMID:
27038550
Items per page

Supplemental Content

Write to the Help Desk